Friedman H M, Grossman R A, Plotkin S A, Perloff L J, Barker C F
J Infect Dis. 1979 Apr;139(4):465-73. doi: 10.1093/infdis/139.4.465.
Two cases of relapse of pneumonia caused by cytomegalovirus (CMV) in recipients of renal transplants were studied. Between episodes of pneumonia, both patients recovered completely as judged by X-ray clearing and by resolution of fever and respiratory symptoms. CMV was isolated during each episode of pneumonia from lung tissue, pleural fluid, or buffy coat cultures. Serologic studies revealed a rise in titer of antibody, confirming recent infection with CMV during the first epidose of pneumonia in each patient. Intranuclear inclusions consistent with CMV infection were detected in each of the three episodes where lung tissue was obtained. Special stains and cultures for Pneumocystis carinii, fungi, Nocardia, and mycobacteria yielded negative results. The renal allograft continued to function in both patients after they recovered from the first bout of pneumonia, and the relapse was temporally related to reinstitution of aggressive immunosuppressive therapy. The relapse of pneumonia emphasizes the need for caution when immunosuppressive therapy is reinstituted after recovery from serious CMV infection.
对两例肾移植受者巨细胞病毒(CMV)肺炎复发病例进行了研究。在肺炎发作期间,根据X线检查结果以及发热和呼吸道症状的消退情况判断,两名患者均已完全康复。在每次肺炎发作期间,均从肺组织、胸腔积液或血沉棕黄层培养物中分离出CMV。血清学研究显示抗体滴度升高,证实每名患者在首次肺炎发作期间近期感染了CMV。在获取肺组织的三次发作中,每次均检测到与CMV感染一致的核内包涵体。针对卡氏肺孢子虫、真菌、诺卡菌和分枝杆菌的特殊染色及培养结果均为阴性。两名患者从首次肺炎发作中康复后,肾移植均继续发挥功能,且复发与强化免疫抑制治疗的重新开始在时间上相关。肺炎复发强调了在严重CMV感染康复后重新开始免疫抑制治疗时需谨慎的必要性。